Romiplostim for management of chemotherapy-induced thrombocytopenia

Author： Parameswaran R.   Lunning M.   Mantha S.   Devlin S.   Hamilton A.   Schwartz G.   Soff G.  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.22, Iss.5, 2014-05, pp. : 1217-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy of Romiplostim in the Treatment of Chemotherapy Induced Thrombocytopenia (CIT) in a Patient with Mantle Cell Lymphoma

By Demeter Judit  

Pathology & Oncology Research, Vol. 17, Iss. 1, 2011-03 ,pp. : 141-143

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy-Associated Thrombocytopenia: Current and Emerging Management Strategies

By Jelic Svetislav  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 371-382

Adis International

Access to resources Recommend Favorite

Chemotherapy-induced Onycholysis

By Makris A.   Mortimer P.   Powles T.J.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 374-375

Elsevier

Access to resources Recommend Favorite

Octreotide Treatment of Chemotherapy-induced Diarrhoea

By Ginopoulos P.   Papagiannis T.   Safridi C.   Karvelas F.   Spyropoulos K.   Papadas T.   Gogos C.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 182-183

Elsevier

Access to resources Recommend Favorite

Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center

By Abernethy Amy   Barbour Sally   Uronis Hope   Zafar S.   Coan April   Rowe Krista   Pupa Mary   Wheeler Jane   Herndon II James  

Supportive Care in Cancer, Vol. 17, Iss. 6, 2009-06 ,pp. : 735-744

Springer Publishing Company

Access to resources Recommend Favorite